Cargando…
Adult Primary Retroperitoneal Lymphangioma: Updated Facts
Lymphangioma is a rare, benign tumor of the lymphatic system. It is believed to be a congenital malformation, when part of the lymphatic channels fail to connect to the main lymphatic system. Lymphangioma is a tumor of the pediatric age, with 50% of patients presenting at birth. The head and neck ar...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990737/ https://www.ncbi.nlm.nih.gov/pubmed/36896002 http://dx.doi.org/10.14740/wjon1561 |
_version_ | 1784901998330511360 |
---|---|
author | Mansour, Subhi Kluger, Yoram Khuri, Safi |
author_facet | Mansour, Subhi Kluger, Yoram Khuri, Safi |
author_sort | Mansour, Subhi |
collection | PubMed |
description | Lymphangioma is a rare, benign tumor of the lymphatic system. It is believed to be a congenital malformation, when part of the lymphatic channels fail to connect to the main lymphatic system. Lymphangioma is a tumor of the pediatric age, with 50% of patients presenting at birth. The head and neck are the main affected sites (75%), while the retroperitoneal cavity is the least affected area, and comprises less than 1% of cases. Adult lymphangioma is an extremely rare tumor, and adult retroperitoneal lymphangioma (ARL) is even a rarer tumor. Over the last two decades, we have experienced a significant increase in reports published in the English literature discussing ARL. As reports have increased, several questions about previously known facts regarding this tumor arose: For years, it was known that ARL is usually an asymptomatic tumor which is incidentally found - is it a true claim? Is abdominal magnetic resonance imaging the radiological test of choice for diagnosis? What is the best therapeutic option? The main aim for this article is to review the current and old English literature concerning ARL, in order to collect data regarding demographic features, clinical presentation, imaging tests used for diagnosis, therapeutic options and follow-up. This in turn will give precise updated answers for the previous questions. In addition, it will raise awareness for the treating physician regarding the most effective approach for early diagnosis and best therapeutic option to be selected. |
format | Online Article Text |
id | pubmed-9990737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-99907372023-03-08 Adult Primary Retroperitoneal Lymphangioma: Updated Facts Mansour, Subhi Kluger, Yoram Khuri, Safi World J Oncol Review Lymphangioma is a rare, benign tumor of the lymphatic system. It is believed to be a congenital malformation, when part of the lymphatic channels fail to connect to the main lymphatic system. Lymphangioma is a tumor of the pediatric age, with 50% of patients presenting at birth. The head and neck are the main affected sites (75%), while the retroperitoneal cavity is the least affected area, and comprises less than 1% of cases. Adult lymphangioma is an extremely rare tumor, and adult retroperitoneal lymphangioma (ARL) is even a rarer tumor. Over the last two decades, we have experienced a significant increase in reports published in the English literature discussing ARL. As reports have increased, several questions about previously known facts regarding this tumor arose: For years, it was known that ARL is usually an asymptomatic tumor which is incidentally found - is it a true claim? Is abdominal magnetic resonance imaging the radiological test of choice for diagnosis? What is the best therapeutic option? The main aim for this article is to review the current and old English literature concerning ARL, in order to collect data regarding demographic features, clinical presentation, imaging tests used for diagnosis, therapeutic options and follow-up. This in turn will give precise updated answers for the previous questions. In addition, it will raise awareness for the treating physician regarding the most effective approach for early diagnosis and best therapeutic option to be selected. Elmer Press 2023-02 2023-02-26 /pmc/articles/PMC9990737/ /pubmed/36896002 http://dx.doi.org/10.14740/wjon1561 Text en Copyright 2023, Khuri et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Mansour, Subhi Kluger, Yoram Khuri, Safi Adult Primary Retroperitoneal Lymphangioma: Updated Facts |
title | Adult Primary Retroperitoneal Lymphangioma: Updated Facts |
title_full | Adult Primary Retroperitoneal Lymphangioma: Updated Facts |
title_fullStr | Adult Primary Retroperitoneal Lymphangioma: Updated Facts |
title_full_unstemmed | Adult Primary Retroperitoneal Lymphangioma: Updated Facts |
title_short | Adult Primary Retroperitoneal Lymphangioma: Updated Facts |
title_sort | adult primary retroperitoneal lymphangioma: updated facts |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990737/ https://www.ncbi.nlm.nih.gov/pubmed/36896002 http://dx.doi.org/10.14740/wjon1561 |
work_keys_str_mv | AT mansoursubhi adultprimaryretroperitoneallymphangiomaupdatedfacts AT klugeryoram adultprimaryretroperitoneallymphangiomaupdatedfacts AT khurisafi adultprimaryretroperitoneallymphangiomaupdatedfacts |